{
  "company": {
    "name": "MinervaX",
    "website": "https://minervax.com/",
    "record": "https://startuphistory.org/c/minervax.com"
  },
  "status": null,
  "history_since": "2011-02-01T20:37:19.000Z",
  "baseline": {
    "snapshot_id": "c6adafee0b1b1f0d661c440eb993a6c68a9bb49b6bebfddd893e1320cb95024d",
    "observed_at": "2011-02-01T20:37:19.000Z",
    "headline": "Minervax - Frontpage",
    "description": null,
    "evidence": "https://web.archive.org/web/20110201203719/http://www.minervax.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:41:31.438Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2018-07-24T02:56:26.000Z",
      "variants": [
        {
          "headline": "Minervax - Frontpage",
          "subhead": null,
          "observed_at": "2011-02-01T20:37:19.000Z",
          "evidence": "https://web.archive.org/web/20110201203719/http://www.minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Minervax - Frontpage",
          "subhead": null,
          "observed_at": "2012-02-10T05:42:06.000Z",
          "evidence": "https://web.archive.org/web/20120210054206/http://www.minervax.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Minervax - Frontpage",
          "subhead": null,
          "observed_at": "2014-01-02T08:53:53.000Z",
          "evidence": "https://web.archive.org/web/20140102085353/http://minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Minervax - Frontpage",
          "subhead": null,
          "observed_at": "2018-07-24T02:56:26.000Z",
          "evidence": "https://web.archive.org/web/20180724025626/http://minervax.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Minervax - Frontpage",
      "subhead": null,
      "from": "2011-02-01T20:37:19.000Z",
      "to": "2018-07-24T02:56:26.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20180724025626/http://minervax.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2011-02-01T20:37:19.000Z",
          "to": "2018-07-24T02:56:26.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2023-02-01T09:53:35.000Z",
      "variants": [
        {
          "headline": "Developing a maternal vaccine against Group B Streptococcus",
          "subhead": "Home - MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity.",
          "observed_at": "2021-04-19T09:34:46.000Z",
          "evidence": "https://web.archive.org/web/20210419093446/https://www.minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing a maternal vaccine against Group B Streptococcus",
          "subhead": "MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein: click to read more",
          "observed_at": "2022-01-21T11:01:33.000Z",
          "evidence": "https://web.archive.org/web/20220121110133/https://www.minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing a maternal vaccine against Group B Streptococcus",
          "subhead": "MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein: click to read more",
          "observed_at": "2023-02-01T09:53:35.000Z",
          "evidence": "https://web.archive.org/web/20230201095335/https://www.minervax.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Developing a maternal vaccine against Group B Streptococcus",
      "subhead": "MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein: click to read more",
      "from": "2021-04-19T09:34:46.000Z",
      "to": "2023-02-01T09:53:35.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20230201095335/https://www.minervax.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-04-19T09:34:46.000Z",
          "to": "2023-02-01T09:53:35.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:41:31.438Z",
      "variants": [
        {
          "headline": "Towards the Development of Life-Saving Vaccines",
          "subhead": "We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.",
          "observed_at": "2024-07-24T17:51:30.000Z",
          "evidence": "https://web.archive.org/web/20240724175130/https://minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Towards the Development of Life-Saving Vaccines",
          "subhead": "We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.",
          "observed_at": "2025-07-08T23:36:58.000Z",
          "evidence": "https://web.archive.org/web/20250708233658/https://minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Towards the Development of Life-Saving Vaccines",
          "subhead": "We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.",
          "observed_at": "2026-09-14T01:16:20.000Z",
          "evidence": "https://web.archive.org/web/20260914011620/https://minervax.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Towards the Development of Life-Saving Vaccines",
          "subhead": "We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.",
          "observed_at": "2026-11-06T17:41:31.438Z",
          "evidence": "https://minervax.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Towards the Development of Life-Saving Vaccines",
      "subhead": "We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.",
      "from": "2024-07-24T17:51:30.000Z",
      "to": "2026-11-06T17:41:31.438Z",
      "captures": 4,
      "evidence": "https://minervax.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-07-24T17:51:30.000Z",
          "to": "2026-11-06T17:41:31.438Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-327d64c47367600c844500f6a817cd50b444e48f09e3eb2a7d23b4d7ab1b1373:9d536d68d24474fb480c706aab22dc5fea69ed0a08293898c271ad09de749ec2:headline:342061b7d9185e96",
      "before_evidence": "https://web.archive.org/web/20230201095335/https://www.minervax.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Developing a maternal vaccine against Group B Streptococcus” to “Towards the Development of Life-Saving Vaccines”.",
      "between": {
        "from": "2023-02-01T09:53:35.000Z",
        "to": "2024-07-24T17:51:30.000Z"
      },
      "evidence": "https://web.archive.org/web/20240724175130/https://minervax.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “MinervaX” company record, https://startuphistory.org/c/minervax.com"
}